14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.43 $5.83 Wednesday, 1st May 2024 ELEV stock ended at $4.00. This is 12.68% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 30.32% from a day low at $3.43 to a day high of $4.47.
90 days $2.50 $5.83
52 weeks $0.363 $5.89

Historical Elevation Oncology, Inc. prices

Date Open High Low Close Volume
May 01, 2024 $3.59 $4.47 $3.43 $4.00 2 656 125
Apr 30, 2024 $3.79 $4.05 $3.55 $3.55 2 037 042
Apr 29, 2024 $3.65 $3.89 $3.51 $3.85 629 260
Apr 26, 2024 $3.68 $3.83 $3.58 $3.62 872 449
Apr 25, 2024 $3.89 $3.92 $3.46 $3.65 1 230 786
Apr 24, 2024 $4.29 $4.35 $3.88 $3.88 655 451
Apr 23, 2024 $4.06 $4.49 $4.06 $4.32 327 428
Apr 22, 2024 $3.80 $4.10 $3.70 $4.05 485 297
Apr 19, 2024 $4.00 $4.07 $3.75 $3.80 987 726
Apr 18, 2024 $4.11 $4.16 $3.96 $4.01 318 669
Apr 17, 2024 $4.37 $4.37 $4.07 $4.14 495 183
Apr 16, 2024 $4.48 $4.53 $4.16 $4.39 787 791
Apr 15, 2024 $4.73 $4.87 $4.38 $4.43 609 935
Apr 12, 2024 $4.92 $4.92 $4.50 $4.73 617 382
Apr 11, 2024 $4.65 $4.98 $4.61 $4.94 374 421
Apr 10, 2024 $4.59 $4.67 $4.51 $4.60 249 972
Apr 09, 2024 $4.68 $4.75 $4.54 $4.71 449 170
Apr 08, 2024 $4.86 $4.86 $4.40 $4.64 774 893
Apr 05, 2024 $5.14 $5.14 $4.59 $4.91 1 079 074
Apr 04, 2024 $5.25 $5.59 $4.81 $5.06 1 202 261
Apr 03, 2024 $5.00 $5.83 $4.98 $5.17 2 043 984
Apr 02, 2024 $4.99 $5.21 $4.90 $5.13 3 448 146
Apr 01, 2024 $5.19 $5.21 $4.78 $4.99 399 333
Mar 28, 2024 $5.04 $5.26 $4.92 $5.13 438 259
Mar 27, 2024 $5.14 $5.39 $4.90 $5.01 1 282 347
Click to get the best stock tips daily for free!

About Elevation Oncology, Inc.

Elevation Oncology. Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is bas... ELEV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT